Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome
NCT00004274 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260
Last updated 2005-06-24
Summary
RATIONALE: Turner's syndrome is a disease in which females are missing all or part of one X chromosome and do not produce estrogen. Giving estrogen is standard treatment for girls who have Turner's syndrome. Estrogen may be effective treatment for mental and social functioning problems experienced by girls with Turner's syndrome.
PURPOSE: Clinical trial to study the effectiveness of long term estrogen therapy on mental and social functioning in girls who have Turner's syndrome.
Conditions
- Turner's Syndrome
Interventions
- DRUG
Sponsors & Collaborators
-
Jefferson Medical College of Thomas Jefferson University
collaborator OTHER -
National Institute of Neurological Disorders and Stroke (NINDS)
lead NIH
Principal Investigators
-
Judith Levine Ross · Jefferson Medical College of Thomas Jefferson University
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 8 Years
- Max Age
- 12 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1990-02-28
Countries
- United States
Study Locations
More Related Trials
-
Transdermal Estrogen in Women With Anorexia Nervosa
NCT03875378 ·Status: RECRUITING ·Phase: PHASE2
-
Progesterone in Gender Affirming Hormone Therapy Study
NCT06807580 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors
NCT04551144 ·Status: TERMINATED
-
Evaluation of the Effectiveness of Hormonal Treatment in Adolescents Suffering from Gender Dysphoria
NCT06351501 ·Status: RECRUITING ·Phase: PHASE3
-
Estrogen Use in Protection From Cognitive Decline
NCT00097058 ·Status: COMPLETED
-
Effects of a Tissue Selective Estrogen Complex (TSEC) on Depression and the Neural Reward System in the Perimenopause"
NCT03740009 ·Status: COMPLETED ·Phase: PHASE4
-
Alzheimer's Disease Prevention Trial
NCT00000176 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy
NCT00179426 ·Status: COMPLETED
-
Vaginal Estrogen Treatment and Effect on Hemostatic Parameters in Postmenopausal Women
NCT07160504 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
NCT04838249 ·Status: RECRUITING
-
Neurocognitive Mechanisms of Perimenstrual Estrogen Effects on Suicidality
NCT06191289 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women
NCT02224313 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Estrogen Withdrawal on Mood Symptoms in Women
NCT00060736 ·Status: COMPLETED
-
Extracellular Vesicles and Endothelial Function in Transgender Subjects
NCT04971447 ·Status: UNKNOWN ·Phase: NA
-
Effect of Race on Gonadotropin Responses
NCT00455962 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
NCT06969326 ·Status: RECRUITING ·Phase: PHASE3
-
The Anabolic Effects of Estrogen on Skeletal Muscles
NCT03020953 ·Status: COMPLETED ·Phase: NA
-
Timing Estrogen After MenoPaUSe
NCT01605071 ·Status: COMPLETED ·Phase: NA
-
Coagulation and Fibrinolysis of Estradiol in Transwomen
NCT05387577 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Alzheimer's Disease: Therapeutic Potential of Estrogen
NCT00066157 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
NCT02253173 ·Status: COMPLETED ·Phase: PHASE3
-
Estrogen Hormone Products
NCT05645406 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of Estrogen Treatment on Drug Metabolism and Transport
NCT05469204 ·Status: COMPLETED ·Phase: PHASE4
-
To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.
NCT02668796 ·Status: COMPLETED ·Phase: PHASE3
-
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 ·Status: COMPLETED ·Phase: PHASE2/PHASE3